B01 Varicella [chickenpox]

Name of the Condition

• Varicella [chickenpox]

Summary

Varicella, commonly known as chickenpox, is a highly contagious viral infection characterized by a pruritic, vesicular rash that progresses to scabs. The condition primarily affects children but can occur in individuals of any age. It is typically self-limiting in healthy populations but may lead to complications in certain groups.

Causes

Varicella is caused by the varicella-zoster virus (VZV), a member of the Herpesviridae family. Transmission occurs through direct contact with vesicular fluid or respiratory droplets from an infected individual. The virus replicates in the respiratory tract before spreading to the skin, resulting in the characteristic rash.

Risk Factors

• Lack of prior vaccination or previous infection.
• Close contact with an infected person, especially in enclosed settings.
• Immunocompromised states, such as HIV/AIDS, chemotherapy, or chronic steroid use.
• Pregnancy, which increases the risk of severe maternal and fetal complications.
• Age, with infants and adults at higher risk for severe disease.

Symptoms

• Initial flu-like symptoms (fever, fatigue, headache) preceding the rash.
• Pruritic (itchy) maculopapular rash that progresses to vesicles, then pustules, and finally scabs.
• Rash typically starts on the trunk and spreads to the face, limbs, and mucous membranes.
• New lesions may appear for several days, leading to crops of lesions at different stages.

Diagnosis

Diagnosis is often clinical, based on the characteristic rash and history of exposure. Laboratory confirmation may be obtained through viral culture, PCR testing of vesicular fluid, or serologic testing for VZV antibodies. Imaging or other tests are rarely needed unless complications are suspected.

Treatment Options

• Supportive care, including antipyretics and antihistamines for itching.
• Antiviral medications (e.g., acyclovir, valacyclovir) for high-risk individuals or severe cases.
• Prevention of secondary bacterial infections through hygiene and monitoring for signs of infection.
• Vaccination is the primary preventive measure and may be used post-exposure in certain cases.

Prognosis and Follow-Up

In healthy individuals, varicella is usually self-resolving within 1–2 weeks. Follow-up is generally not required unless complications arise. Immunocompromised patients or those with severe disease may need closer monitoring and extended antiviral therapy.

Complications

• Bacterial skin infections (e.g., cellulitis) from scratching lesions.
• Pneumonia, especially in adults or immunocompromised individuals.
• Neurological complications, such as cerebellar ataxia or encephalitis.
• Hemorrhagic varicella in severe cases.
• Fetal varicella syndrome if infection occurs during pregnancy.

Lifestyle & Prevention

• Vaccination with the varicella vaccine is the most effective preventive measure.
• Avoidance of contact with infected individuals, particularly in high-risk settings.
• Good hygiene practices, including handwashing and avoiding scratching lesions.
• Isolation of infected individuals until lesions have crusted over (typically 5–7 days).

When to Seek Professional Help

• If symptoms worsen or do not improve after a week.
• Presence of high fever, severe headache, or confusion.
• Signs of bacterial infection (e.g., redness, swelling, pus).
• Respiratory symptoms (e.g., cough, difficulty breathing).
• Immunocompromised status or pregnancy with suspected exposure.

Tips for Medical Coders

• Code B01 is used for varicella (chickenpox) without further specification. Documentation should confirm the diagnosis and any associated complications or risk factors. Ensure the code aligns with clinical findings and avoid using it for zoster (shingles), which is coded separately.